Prediction of long-term effect of anti-angiogenic therapy in lung cancer patients by monitoring early changes in circulating-tumor DNA (ctDNA).

M. Pešek (Plzen, Czech Republic), B. Lucie (Prague, Czech Republic), M. Svaton (Plzen, Czech Republic), B. Belsanova (Prague, Czech Republic), R. Ptackova (Prague, Czech Republic), O. Fiala (Pilsen, Czech Republic), M. Minarik (Prague, Czech Republic)

Source: Virtual Congress 2020 – Biological aspects of lung cancer
Session: Biological aspects of lung cancer
Session type: Oral Presentation
Number: 3941
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Pešek (Plzen, Czech Republic), B. Lucie (Prague, Czech Republic), M. Svaton (Plzen, Czech Republic), B. Belsanova (Prague, Czech Republic), R. Ptackova (Prague, Czech Republic), O. Fiala (Pilsen, Czech Republic), M. Minarik (Prague, Czech Republic). Prediction of long-term effect of anti-angiogenic therapy in lung cancer patients by monitoring early changes in circulating-tumor DNA (ctDNA).. 3941

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: